InvestorsHub Logo
Followers 971
Posts 383019
Boards Moderated 6
Alias Born 06/24/2011

Re: None

Tuesday, 11/14/2023 10:20:18 AM

Tuesday, November 14, 2023 10:20:18 AM

Post# of 118371
"Having had confirmatory studies supporting the increase in NR2F6 gene expression, we now want to see what is happening when these cells are put in a relatively natural environment in the presence of activated immune cells, " says Dr. David Koos, Chairman and CEO of the company. "If these cells do indeed suppress these immune cells, then we will have in hand a potentially extremely valuable approach to suppressing autoimmunity."